MARKET INTRODUCTION
Intravenous solutions are fluids with medicines, salts, minerals, vitamins, and more. These solutions are given to replace water, sugar, and salt for a patient living with chronic health conditions. It helps in resolving the imbalance of water in the body and restores normal functions. The IV solution is directly injected in the vein through a drip and requires monitoring.
MARKET DYNAMICS
The intravenous (IV) solutions market growth is estimated to grow due to rising demand by the end-users, growing incidences of chronic diseases, growing pharmaceutical production. The never-ending demand from the hospital segment is expected to serve vital growth opportunities during the forecast period.
MARKET SCOPE
The "Intravenous (IV) Solutions Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of intravenous (IV) solutions market with detailed market segmentation by solution, bag type, and end user. The intravenous (IV) solutions market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in intravenous (IV) solutions market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The intravenous (IV) solutions market is segmented on the basis of, solution, bag type, and end user. Based on solution, the market is divided into saline, dextran, lactated ringer's, amino acid, vitamins and minerals, heparin and trace elements, and mixed solutions. Based on bag type, the market is divided into large volume bags, and small volume bags. And based on end user, the market is classified as hospitals and clinics, ambulatory surgery centers, and home care settings.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the intravenous (IV) solutions market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The intravenous (IV) solutions market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting intravenous (IV) solutions market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the intravenous (IV) solutions market in these regions.
MARKET PLAYERS
The report covers key developments in the intravenous (IV) solutions market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from intravenous (IV) solutions market are anticipated to have lucrative growth opportunities in the future with the rising demand for intravenous (IV) solutions in the global market. Below mentioned is the list of few companies engaged in the intravenous (IV) solutions market.
The report also includes the profiles of key players in intravenous (IV) solutions market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Baxter International Inc.
- ICU Medical, Inc.
- Grifols, S.A.
- B. Braun Melsungen AG
- Fresenius Kabi
- Amanta Healthcare
- JW Life Science
- Soxa Formulations and Research (Pvt.) Ltd
- AXA Parenterals Ltd.
- Otsuka Pharmaceutical Co., Ltd
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. PUBLISHERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Intravenous (IV) Solutions Market - By Solution
1.3.2 Intravenous (IV) Solutions Market - By Bag Type
1.3.3 Intravenous (IV) Solutions Market - By End-user
1.3.4 Intravenous (IV) Solutions Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INTRAVENOUS (IV) SOLUTIONS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INTRAVENOUS (IV) SOLUTIONS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INTRAVENOUS (IV) SOLUTIONS MARKET - GLOBAL MARKET ANALYSIS
6.1. INTRAVENOUS (IV) SOLUTIONS - GLOBAL MARKET OVERVIEW
6.2. INTRAVENOUS (IV) SOLUTIONS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. INTRAVENOUS (IV) SOLUTIONS MARKET - REVENUE AND FORECASTS TO 2027 - SOLUTION
7.1. OVERVIEW
7.2. SOLUTION MARKET FORECASTS AND ANALYSIS
7.3. SALINE
7.3.1. Overview
7.3.2. Saline Market Forecast and Analysis
7.4. DEXTRAN
7.4.1. Overview
7.4.2. Dextran Market Forecast and Analysis
7.5. LACTATED RINGER'S
7.5.1. Overview
7.5.2. Lactated Ringer's Market Forecast and Analysis
7.6. AMINO ACID
7.6.1. Overview
7.6.2. Amino Acid Market Forecast and Analysis
7.7. VITAMINS AND MINERALS
7.7.1. Overview
7.7.2. Vitamins and Minerals Market Forecast and Analysis
7.8. HEPARIN AND TRACE ELEMENTS
7.8.1. Overview
7.8.2. Heparin and Trace Elements Market Forecast and Analysis
7.9. MIXED SOLUTIONS
7.9.1. Overview
7.9.2. Mixed Solutions Market Forecast and Analysis
8. INTRAVENOUS (IV) SOLUTIONS MARKET - REVENUE AND FORECASTS TO 2027 - BAG TYPE
8.1. OVERVIEW
8.2. BAG TYPE MARKET FORECASTS AND ANALYSIS
8.3. LARGE VOLUME BAGS
8.3.1. Overview
8.3.2. Large Volume Bags Market Forecast and Analysis
8.4. SMALL VOLUME BAGS
8.4.1. Overview
8.4.2. Small Volume Bags Market Forecast and Analysis
9. INTRAVENOUS (IV) SOLUTIONS MARKET - REVENUE AND FORECASTS TO 2027 - END-USER
9.1. OVERVIEW
9.2. END-USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS AND CLINICS
9.3.1. Overview
9.3.2. Hospitals and Clinics Market Forecast and Analysis
9.4. AMBULATORY SURGERY CENTERS
9.4.1. Overview
9.4.2. Ambulatory Surgery Centers Market Forecast and Analysis
9.5. HOME CARE SETTINGS
9.5.1. Overview
9.5.2. Home Care Settings Market Forecast and Analysis
10. INTRAVENOUS (IV) SOLUTIONS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Intravenous (IV) Solutions Market Overview
10.1.2 North America Intravenous (IV) Solutions Market Forecasts and Analysis
10.1.3 North America Intravenous (IV) Solutions Market Forecasts and Analysis - By Solution
10.1.4 North America Intravenous (IV) Solutions Market Forecasts and Analysis - By Bag Type
10.1.5 North America Intravenous (IV) Solutions Market Forecasts and Analysis - By End-user
10.1.6 North America Intravenous (IV) Solutions Market Forecasts and Analysis - By Countries
10.1.6.1 United States Intravenous (IV) Solutions Market
10.1.6.1.1 United States Intravenous (IV) Solutions Market by Solution
10.1.6.1.2 United States Intravenous (IV) Solutions Market by Bag Type
10.1.6.1.3 United States Intravenous (IV) Solutions Market by End-user
10.1.6.2 Canada Intravenous (IV) Solutions Market
10.1.6.2.1 Canada Intravenous (IV) Solutions Market by Solution
10.1.6.2.2 Canada Intravenous (IV) Solutions Market by Bag Type
10.1.6.2.3 Canada Intravenous (IV) Solutions Market by End-user
10.1.6.3 Mexico Intravenous (IV) Solutions Market
10.1.6.3.1 Mexico Intravenous (IV) Solutions Market by Solution
10.1.6.3.2 Mexico Intravenous (IV) Solutions Market by Bag Type
10.1.6.3.3 Mexico Intravenous (IV) Solutions Market by End-user
10.2. EUROPE
10.2.1 Europe Intravenous (IV) Solutions Market Overview
10.2.2 Europe Intravenous (IV) Solutions Market Forecasts and Analysis
10.2.3 Europe Intravenous (IV) Solutions Market Forecasts and Analysis - By Solution
10.2.4 Europe Intravenous (IV) Solutions Market Forecasts and Analysis - By Bag Type
10.2.5 Europe Intravenous (IV) Solutions Market Forecasts and Analysis - By End-user
10.2.6 Europe Intravenous (IV) Solutions Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Intravenous (IV) Solutions Market
10.2.6.1.1 Germany Intravenous (IV) Solutions Market by Solution
10.2.6.1.2 Germany Intravenous (IV) Solutions Market by Bag Type
10.2.6.1.3 Germany Intravenous (IV) Solutions Market by End-user
10.2.6.2 France Intravenous (IV) Solutions Market
10.2.6.2.1 France Intravenous (IV) Solutions Market by Solution
10.2.6.2.2 France Intravenous (IV) Solutions Market by Bag Type
10.2.6.2.3 France Intravenous (IV) Solutions Market by End-user
10.2.6.3 Italy Intravenous (IV) Solutions Market
10.2.6.3.1 Italy Intravenous (IV) Solutions Market by Solution
10.2.6.3.2 Italy Intravenous (IV) Solutions Market by Bag Type
10.2.6.3.3 Italy Intravenous (IV) Solutions Market by End-user
10.2.6.4 Spain Intravenous (IV) Solutions Market
10.2.6.4.1 Spain Intravenous (IV) Solutions Market by Solution
10.2.6.4.2 Spain Intravenous (IV) Solutions Market by Bag Type
10.2.6.4.3 Spain Intravenous (IV) Solutions Market by End-user
10.2.6.5 United Kingdom Intravenous (IV) Solutions Market
10.2.6.5.1 United Kingdom Intravenous (IV) Solutions Market by Solution
10.2.6.5.2 United Kingdom Intravenous (IV) Solutions Market by Bag Type
10.2.6.5.3 United Kingdom Intravenous (IV) Solutions Market by End-user
10.2.6.6 Rest of Europe Intravenous (IV) Solutions Market
10.2.6.6.1 Rest of Europe Intravenous (IV) Solutions Market by Solution
10.2.6.6.2 Rest of Europe Intravenous (IV) Solutions Market by Bag Type
10.2.6.6.3 Rest of Europe Intravenous (IV) Solutions Market by End-user
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Intravenous (IV) Solutions Market Overview
10.3.2 Asia-Pacific Intravenous (IV) Solutions Market Forecasts and Analysis
10.3.3 Asia-Pacific Intravenous (IV) Solutions Market Forecasts and Analysis - By Solution
10.3.4 Asia-Pacific Intravenous (IV) Solutions Market Forecasts and Analysis - By Bag Type
10.3.5 Asia-Pacific Intravenous (IV) Solutions Market Forecasts and Analysis - By End-user
10.3.6 Asia-Pacific Intravenous (IV) Solutions Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Intravenous (IV) Solutions Market
10.3.6.1.1 Australia Intravenous (IV) Solutions Market by Solution
10.3.6.1.2 Australia Intravenous (IV) Solutions Market by Bag Type
10.3.6.1.3 Australia Intravenous (IV) Solutions Market by End-user
10.3.6.2 China Intravenous (IV) Solutions Market
10.3.6.2.1 China Intravenous (IV) Solutions Market by Solution
10.3.6.2.2 China Intravenous (IV) Solutions Market by Bag Type
10.3.6.2.3 China Intravenous (IV) Solutions Market by End-user
10.3.6.3 India Intravenous (IV) Solutions Market
10.3.6.3.1 India Intravenous (IV) Solutions Market by Solution
10.3.6.3.2 India Intravenous (IV) Solutions Market by Bag Type
10.3.6.3.3 India Intravenous (IV) Solutions Market by End-user
10.3.6.4 Japan Intravenous (IV) Solutions Market
10.3.6.4.1 Japan Intravenous (IV) Solutions Market by Solution
10.3.6.4.2 Japan Intravenous (IV) Solutions Market by Bag Type
10.3.6.4.3 Japan Intravenous (IV) Solutions Market by End-user
10.3.6.5 South Korea Intravenous (IV) Solutions Market
10.3.6.5.1 South Korea Intravenous (IV) Solutions Market by Solution
10.3.6.5.2 South Korea Intravenous (IV) Solutions Market by Bag Type
10.3.6.5.3 South Korea Intravenous (IV) Solutions Market by End-user
10.3.6.6 Rest of Asia-Pacific Intravenous (IV) Solutions Market
10.3.6.6.1 Rest of Asia-Pacific Intravenous (IV) Solutions Market by Solution
10.3.6.6.2 Rest of Asia-Pacific Intravenous (IV) Solutions Market by Bag Type
10.3.6.6.3 Rest of Asia-Pacific Intravenous (IV) Solutions Market by End-user
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Intravenous (IV) Solutions Market Overview
10.4.2 Middle East and Africa Intravenous (IV) Solutions Market Forecasts and Analysis
10.4.3 Middle East and Africa Intravenous (IV) Solutions Market Forecasts and Analysis - By Solution
10.4.4 Middle East and Africa Intravenous (IV) Solutions Market Forecasts and Analysis - By Bag Type
10.4.5 Middle East and Africa Intravenous (IV) Solutions Market Forecasts and Analysis - By End-user
10.4.6 Middle East and Africa Intravenous (IV) Solutions Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Intravenous (IV) Solutions Market
10.4.6.1.1 South Africa Intravenous (IV) Solutions Market by Solution
10.4.6.1.2 South Africa Intravenous (IV) Solutions Market by Bag Type
10.4.6.1.3 South Africa Intravenous (IV) Solutions Market by End-user
10.4.6.2 Saudi Arabia Intravenous (IV) Solutions Market
10.4.6.2.1 Saudi Arabia Intravenous (IV) Solutions Market by Solution
10.4.6.2.2 Saudi Arabia Intravenous (IV) Solutions Market by Bag Type
10.4.6.2.3 Saudi Arabia Intravenous (IV) Solutions Market by End-user
10.4.6.3 U.A.E Intravenous (IV) Solutions Market
10.4.6.3.1 U.A.E Intravenous (IV) Solutions Market by Solution
10.4.6.3.2 U.A.E Intravenous (IV) Solutions Market by Bag Type
10.4.6.3.3 U.A.E Intravenous (IV) Solutions Market by End-user
10.4.6.4 Rest of Middle East and Africa Intravenous (IV) Solutions Market
10.4.6.4.1 Rest of Middle East and Africa Intravenous (IV) Solutions Market by Solution
10.4.6.4.2 Rest of Middle East and Africa Intravenous (IV) Solutions Market by Bag Type
10.4.6.4.3 Rest of Middle East and Africa Intravenous (IV) Solutions Market by End-user
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Intravenous (IV) Solutions Market Overview
10.5.2 South and Central America Intravenous (IV) Solutions Market Forecasts and Analysis
10.5.3 South and Central America Intravenous (IV) Solutions Market Forecasts and Analysis - By Solution
10.5.4 South and Central America Intravenous (IV) Solutions Market Forecasts and Analysis - By Bag Type
10.5.5 South and Central America Intravenous (IV) Solutions Market Forecasts and Analysis - By End-user
10.5.6 South and Central America Intravenous (IV) Solutions Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Intravenous (IV) Solutions Market
10.5.6.1.1 Brazil Intravenous (IV) Solutions Market by Solution
10.5.6.1.2 Brazil Intravenous (IV) Solutions Market by Bag Type
10.5.6.1.3 Brazil Intravenous (IV) Solutions Market by End-user
10.5.6.2 Argentina Intravenous (IV) Solutions Market
10.5.6.2.1 Argentina Intravenous (IV) Solutions Market by Solution
10.5.6.2.2 Argentina Intravenous (IV) Solutions Market by Bag Type
10.5.6.2.3 Argentina Intravenous (IV) Solutions Market by End-user
10.5.6.3 Rest of South and Central America Intravenous (IV) Solutions Market
10.5.6.3.1 Rest of South and Central America Intravenous (IV) Solutions Market by Solution
10.5.6.3.2 Rest of South and Central America Intravenous (IV) Solutions Market by Bag Type
10.5.6.3.3 Rest of South and Central America Intravenous (IV) Solutions Market by End-user
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INTRAVENOUS (IV) SOLUTIONS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. INTRAVENOUS (IV) SOLUTIONS MARKET, KEY COMPANY PROFILES
13.1. BAXTER INTERNATIONAL INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ICU MEDICAL, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. GRIFOLS, S.A.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. B. BRAUN MELSUNGEN AG
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. FRESENIUS KABI
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. AMANTA HEALTHCARE
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. JW LIFE SCIENCE
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. SOXA FORMULATIONS AND RESEARCH (PVT.) LTD
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. AXA PARENTERALS LTD.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. OTSUKA PHARMACEUTICAL CO., LTD
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT PUBLISHERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. Baxter International Inc.
2. ICU Medical, Inc.
3. Grifols, S.A.
4. B. Braun Melsungen AG
5. Fresenius Kabi
6. Amanta Healthcare
7. JW Life Science
8. Soxa Formulations and Research (Pvt.) Ltd
9. AXA Parenterals Ltd.
10. Otsuka Pharmaceutical Co., Ltd
Global Loop-mediated Isothermal Amplific..
According to this latest study, the 2020 growth of Loop-medi..
+1-646-791 7070US (Toll Free)